Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis

Drugs under Experimental and Clinical Research

Volumn 29, Issue 3, 2003, Pages 107-115

  Amit, A ^a   Saxena, V S ^a   Pratibha, N ^a   D'Souza, P ^a   Bagchi, M ^b   Bagchi, D ^b   Stohs, S J ^b  

^a Natural Remedies Pvt Ltd   (India)

^b CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLER 7; ANTIHISTAMINIC AGENT; CETIRIZINE; HISTAMINE; HYALURONIDASE; LIPOXYGENASE; PAPAVERINE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ALBIZIA LEBBECK; ALLERGIC RHINITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLACK PEPPER; CONTROLLED STUDY; DRUG POTENCY; EMBLICA OFFICINALIS; ENZYME INHIBITION; GINGER; ILEUM; MAST CELL DEGRANULATION; MEDICINAL PLANT; NONHUMAN; PIPER LONGUM; RAT; SWINE; TERMINALIA BELLERICA; TERMINALIA CHEBULA;

ANIMALS; BARIUM COMPOUNDS; CARBACHOL; CETIRIZINE; CHLORIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG EVALUATION, PRECLINICAL; GUINEA PIGS; HISTAMINE ANTAGONISTS; HYALURONOGLUCOSAMINIDASE; ILEUM; LIPOXYGENASE INHIBITORS; MAST CELLS; MEDICINE, AYURVEDIC; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; PAPAVERINE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RHINITIS, ALLERGIC, SEASONAL; TRACHEA;

EID: 0344234348     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Taylor M.A., Reilly D., Jones L.R.H., et al. Randomized controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ, 321, 471, 2000.
2. May J.R., Feger T.A., Guill M.F. "Allergic Rhinitis." In: Dipiro J.T., Talbert R.L., Yee G.C., et al. (Eds.). "Pharmacotherapy: A Pathophysiologic Approach." Appleton & Lange, Stamford, CT, USA, 1997, p. 1801.
3. Addison G.M., Beamish M.R., Hales C.N., et al. An immuno-radiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. J. Clin. Pathol., 25, 326, 1972.
4. Wanner A. Clinical aspects of mucociliary transport. Am. Rev. Respir. Dis., 116, 73, 1977.
5. "Management of Allergic Rhinitis and Its Impact on Asthma, A Pocket Guide." Astrazeneca in collaboration with the WHO, Geneva, Switzerland, 2001, pp. 2-23.
6. Tarnasky P.R., Van Arsdel P.P. Jr. Antihistamine therapy in allergic rhinitis. J. Fam. Pract., 30, 71, 1990.
7. Meltzer E.O. Antihistamine- and decongestant-induced performance decrements. J. Occup. Med., 32, 327, 1990.
8. Agnew J.E., Little F., Pavia D., et al. Mucus clearance from the airways in chronic bronchitis: Smokers and ex-smokers. Bull Eur. Physiopathol. Respir., 18, 473, 1982.
9. Lourenco R.V., Loddenkemper R., Carton R.W. Patterns of distribution and clearance of aerosols in patients with bronchiectasis. Am. Rev. Respir. Dis., 106, 857, 1972.
10. Kakegawa H., Matsumoto H., Satoh T. Inhibitory effects of hydrangenol derivatives on the activation of hyaluronidase and their antiallergic activities. Planta Med., 54, 385, 1988.
11. Kakegawa H., Matsumoto H., Endo K. Inhibitory effects of tannins on hyaluronidase activation and on the degranulation from rat mesentery mast cells. Chem. Pharm. Bull. (Tokyo), 33, 5079, 1985.
12. Babe K.S., Serafin W.E. "Histamine, Bradykinin and Their Antagonists." In: Hardman J.G., Limbird L.E., Molinoff P.B., et al. (Eds.). "The Pharmacological Basis of Therapeutics." McGraw-Hill, New York, NY, USA, 1996, p. 581.
13. Serafin W.E. "Drugs Used in the Treatment of Asthma." In: Hardman J.G., Limbird L.E., Molinoff RB., et al. (Eds.). "The Pharmacological Basis of Therapeutics." McGraw-Hill, New York, NY, USA, 1996, p. 659.
14. Rajasekaran M., Sudhakaran C., Pradhan S.C., et al. Mast cell protective activity of ursolic acid-A triterpene from the leaves of Ocimum sanctum. J. Drug Dev., 2 (3), 179, 1989.
15. Shinde U.A., Kulkarni K.R., Phadke A.S., et al. Mast cell stabilizing and lipoxygenase inhibitory activity of Cedrus deodara (Roxb.) Loud. wood oil. Indian J. Exp. Biol., 37, 258, 1999.
16. Asada M., Fukumori N., Yamazaki Y., et al. Glycoprotein derived from the hot water extract of mint plant. Perilla frutescens Britton. J. Agric. Food Chem., 47, 468, 1999.
17. Jeong S.J. Norlignans with hyaluronidase inhibitory activity from Anemarrhena asphodeloides. Planta Med., 65, 367, 1999.
18. Meister A., Bernhardt G., Christoffel V., et al. Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea: Discrimination between drug and ethanol effects. Planta Med., 65, 512, 1999.
19. Saxena V.S., Pratibha N., Amit A., et al. Safety of a novel botanical extract formulation ameliorating allergic rhinitis. Toxicol. Mech. Meth. (in press).